Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?

To: vibaby who wrote (405)	2/9/2000 8:39:00 PM
From: Sir Auric Goldfinger	Respond to of 428

TOTAL PUMPANDUMP: "CYTOCLONAL PHARMACEUTICS INC. ITEM 5. OTHER EVENTS. On February 4, 2000, the registrant issued the press release filed as Exhibit 99.1 hereto and incorporated herein by reference, announcing that it intended to call for redemption its outstanding Class C Warrants for cash at the redemption price of $.05 per Class C Warrant. On February 7, 2000, the registrant distributed to the registered holders of its Class C Warrants the Notice of Redemption of Class C Warrants filed as Exhibit 99.2 hereto. Each Class C Warrant is exercisable at an aggregate exercise price of $6.50 per Class C Warrant prior to 5:00 p.m. (Eastern Standard Time) on March 8, 2000. If a Class C Warrant is exercised, the holder will receive one share of common stock (NASDAQ:CYPH) and one Class D Warrant (NASDAQ:CYPHZ) of Cytoclonal Pharmaceutics Inc. After 5:00 p.m. on March 8, 2000, the Class C Warrants will no longer be exercisable, and the holders will have only the right to receive the redemption price. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. Exhibit Number Description 99.1 Press release issued February 4, 2000. 99.2 Notice of Redemption of Class C Warrants distributed to the registered holders of Class C Warrants. 2 <PAGE> 3 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CYTOCLONAL PHARMACEUTICS INC. Date: February 9, 2000 By:/s/ DANIEL SHUSTERMAN ---------------------------------- Daniel Shusterman Vice President Operations Treasurer and Chief Financial Officer 3 <PAGE> 4 EXHIBIT INDEX <TABLE> <CAPTION> EXHIBIT NUMBER DESCRIPTION ------- ----------- <S> <C> 99.1 Press Release issued February 4, 2000. 99.2 Notice of Redemption of Class C Warrants. </TABLE> </TEXT> </DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <DESCRIPTION>PRESS RELEASE ISSUED FEBRUARY 4, 2000 <TEXT> <PAGE> 1 EXHIBIT 99.1 FOR IMMEDIATE RELEASE Contact: Daniel M. Shusterman Vice President Operations Chief Financial Officer Telephone: (214) 353-2922 extension 401 February 4, 2000 Dallas, Texas CYTOCLONAL PHARMACEUTICS INC. ANNOUNCES CLASS C WARRANT REDEMPTION CALL